top of page
Search

Colorectal Cancer (CRC) Diagnostics and Treatments Market Value, Scope & Growth Outlook 2030

  • Writer: Amit Kumar
    Amit Kumar
  • 1 hour ago
  • 4 min read
ree

The Colorectal Cancer (CRC) Diagnostics and Treatments Market reports delivers an in-depth assessment of market size, share, and emerging trends, offering valuable insights into growth opportunities. It examines market segmentation and definitions, highlighting core components and key drivers of expansion. By applying SWOT and PESTEL analyses, the study evaluates the sector’s strengths, weaknesses, opportunities, and threats, while also considering political, economic, social, technological, environmental, and legal factors. Expert reviews of competitor strategies and recent developments provide a clearer view of regional dynamics and future market trajectories, establishing a strong foundation for strategic planning and informed investment decisions.

What will be the market size of Colorectal Cancer (CRC) Diagnostics and Treatments market 2030?

The Global Colorectal Cancer (CRC) Diagnostics and Treatments Market size was valued at around USD10.89 Billion in 2024 and is projected to reach USD16.89 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.6% during the forecast period, i.e., 2025-30.

Who are the top companies operating in the Colorectal Cancer (CRC) Diagnostics and Treatments market?

The report features prominent companies operating in the Colorectal Cancer (CRC) Diagnostics and Treatments market and the successful strategies they have adopted. It also provides detailed insights into each company’s market share and their role in driving the industry’s growth. As per MarkNtel Advisors, top companies in Colorectal Cancer (CRC) Diagnostics and Treatments market: Abbott Laboratories, Amgen Inc., Bayer AG, Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, Pfizer Inc., and others.

What is the key factor projected to fuel growth in the Colorectal Cancer (CRC) Diagnostics and Treatments Market between 2025 and 2030?

High Ubiquity of Colorectal Cancer Driving Demand – Globally, colorectal cancer is a major health concern. 930,000 people died and 10. 9 million new cases were reported worldwide in 2020. The number of cases is expected to increase to 32. 2 million by 2040, with 12. 6 million expected deaths. The disease is most common in countries with high or extremely high HDI. With 10% of cases worldwide, it is the second most common cause of cancer-related deaths and the third most common type of cancer overall. Different geographic prevalence rates indicate that colorectal cancer (CRC) is most common in Australia, New Zealand, and Europe, while it is less common in some parts of Africa and Southern Asia.

Colorectal Cancer (CRC) Diagnostics and Treatments Market - Segmentation Analysis

  • By Diagnosis (Blood & Stool Tests, Imaging, Biopsy, Flexible Sigmoidoscopy, Colonoscopy),

  • By Treatment (Chemotherapy (Alkylating Agents, Antimetabolites (Fluorouracil, Capecitabine), Others), Immunotherapy (Monoclonal Antibodies (Bevacizumab, Cetuximab, Panitumumab), Biologic Response Modifiers, Colony-Stimulating Factors, Tumor Vaccines), Surgery, Targeted Therapy, Others (Radiofrequency Ablation (RFA), etc.)),

  • By End-User (Hospitals, Specialty Clinics, Others (Ambulatory Surgery Centers, etc.)) and Others

How does the Colorectal Cancer (CRC) Diagnostics and Treatments Market vary across different geography?

By Region

  • North America

  • South America

  • Europe

  • The Middle East & Africa

  • Asia-Pacific

North America leads the Global Colorectal Cancer (CRC) Diagnostics & Treatments Market. It holds approx. 40% share of the total market value.

This Section cover detailed analysis of revenue, market share and growth rate, historical data (2020-23) and forecast (2025-2030) of the following segmentation and geography.

Inquire Before Buying, Connect with our Expertise Today: https://www.marknteladvisors.com/research-library/colorectal-cancer-crc-market.html

Comprehensive Table of Contents – Colorectal Cancer (CRC) Diagnostics and Treatments Market Analysis and Forecast, 2030

  1. Table 1: Introduction

  2. Table 2: Executive Summary

  3. Table 3: Market Regulations, Policies & Standards

  4. Table 4: Colorectal Cancer (CRC) Diagnostics and Treatments Market Size, Share & Scope, 2020-2030F

  5. Table 5: Market Trends & Developments

  6. Table 6: Market Dynamics (Key Drivers, and Challenges)

  7. Table 7: Market Hotspots & Opportunities

  8. Table 8: Market Value Chain Analysis

  9. Table 9: Market Outlook, 2020-2030F

  10. Table 10: Market Size & Analysis by Revenues (USD Million): 

  11. Table 11: Market Size & Forecast 2020–2030 by Segmentation

  12. Table 12: Market Size & Forecast 2020–2030 by Geography

  13. Table 13: Key Strategic Imperatives for Success & Growth

  14. Table 14: Competitor Analysis of Colorectal Cancer (CRC) Diagnostics and Treatments Companies

Key Benefits for Industry Participants and Stakeholders

  • Insight into emerging market trends and investment opportunities

  • Understanding of regional market dynamics and competitive landscapes

  • Data-driven forecasts to support strategic decision-making

  • Access to industry benchmarks for performance evaluation

  • Identification of potential risks and growth challenges

Browse More Reports:

About Us:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

 
 
 

Comentarios

bottom of page